Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “longitudinal changes”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 451 records · Page 25Linked to original sources
PubMed2006

Longitudinal changes in HIV-specific IFN-gamma secretion in subjects who received Remune vaccination prior to treatment interruption.

BACKGROUND: Despite the benefits of highly active antiretroviral therapy (HAART) for suppressing viral replication in HIV infection, virus persists and rebounds during treatment interruption (TI). This study explored whether HAART intensification with Remune vaccination before TI can boost HIV-1-specific immunity, leading to improved control of viremia off HAART. METHODS: Ten chronically HIV-infected adults were enrolled in this proof of concept study. After a 6-month HAART intensification phase with didanosine, hydroxyurea, granulocyte-macrophage colony-stimulating factor, (GM-CSF), and a first dose of Remune (HIV-1 Immunogen), HAART was discontinued. Patients continued to receive Remune every 3 months until the end of study. HAART was restarted if viral load did not fall below 50,000 copies/ml of plasma within 3 months or if CD4+ counts decreased to <200 cells/mm3. HIV-specific immunity was monitored with the interferon-gamma (IFN-gamma) ELISPOT assay. RESULTS: All subjects experienced viral rebound during TIs. Although the magnitude and breadth of HIV-specific responses to HLA-restricted optimal peptide panels and Gag p55 peptide pools increased and viral load decreased by 0.44 log10 units from TI#1 to TI#2, no significant correlations between these parameters were observed. The patients spent 50.4% of their 36 months follow up off HAART. CONCLUSION: Stopping HAART in this vaccinated population induced immune responses that persisted after therapy was restarted. Induction of HIV-specific immunity beyond IFN-gamma secretion may be contributing to better control of viremia during subsequent TIs allowing for long periods off HAART.

Journal Article↗
PubMed1990

Longitudinal changes in growth hormone response to growth hormone-releasing hormone in neonatal rhesus monkeys.

To determine whether differential response to growth hormone-releasing hormone (GHRH) could cause the developmental changes seen in growth hormone (GH) secretion, we administered 10 micrograms/kg GHRH (1-44 NH2) to a group of four unanesthetized, fasted, rhesus monkeys via acutely placed venous catheters at 1, 7, 14, and 28 d postnatal age. Serum GH was assayed by hGH RIA in sera collected at -60, -30, 0, 15, 30, 45, 60, and 90 min relative to the GHRH bolus. Serum cortisol was measured by ELISA in the 0-, 30-, and 60-min samples. Differences between age groups were analyzed by repeated measures analysis of variance and paired t tests. Mean basal GH levels were higher at 1 d (9.4 +/- 1.2 micrograms/L, mean +/- SEM) than at 7 (5.5 +/- 0.4), 14 (5.6 +/- 0.5), and 28 d (5.3 +/- 0.5) of age. There were no other significant differences in mean basal GH values between the age groups. Mean post-GHRH GH concentrations decreased significantly with each age after 1 d (22.6 +/- 1.6): 7 d (16.4 +/- 1.3); 14 d (11.3 +/- 1.0); and 28 d (7.9 +/- 0.9). Similarly, mean delta-GH values decreased with each increase in age from 1 d (15.0 +/- 1.9): 7 d (10.9 +/- 1.6); 14 d (5.9 +/- 1.1); and 28 d (2.7 +/- 0.8). Serum cortisol was not correlated with serum GH at any age. Our study demonstrates decreasing basal GH concentration and GH responses to GHRH with advancing age from 1 to 28 d in the rhesus monkey.(ABSTRACT TRUNCATED AT 250 WORDS)

Age Factors↗
PubMed1996

Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism.

The aims of this study were to determine 1) whether primary hyperparathyroidism (PHPT) is associated with accelerated bone loss in postmenopausal women, 2) whether bone mineral density (BMD) and bone turnover change to a similar extent with surgery and hormone replacement therapy (HRT) in these patients, and 3) whether biochemical markers of bone turnover measured at baseline can be used to predict the change in BMD in these patients after different therapies. We studied 33 postmenopausal women with PHPT; their ages at the time of study ranged from 48-80 yr (mean +/- SD, 63 +/- 10). Total body (TB), lumbar spine (LS), and femoral neck (FN) BMD and biochemical markers of bone turnover were measured at baseline and 10-30 months (19 +/- 5) after parathyroid surgery, HRT, or no treatment. BMD was measured in 33 age-matched healthy controls at baseline and at a mean of 24 months. Baseline biochemical markers of bone turnover were measured in controls. In PHPT at baseline, the mean z-score of BMD was -1.25 at TB (95% confidence interval, -1.64 to -0.86), -0.95 at LS (-1.37 to -0.53), and -1.30 at FN (-1.65 to -0.95), whereas the mean z score was 0.45 for serum carboxy-terminal propeptide of human type I procollagen (0.02-0.89), 1.05 for bone alkaline phosphatase (0.38-1.71), 2.38 for 24-h urinary excretion of cross-linked N-terminal telopeptide of type I collagen (NTx; 1.63-3.13), and 2.36 for 24-h urinary excretion of galactosyl hydroxylysine (1.97-2.74). After surgery and HRT, BMD increased and bone turnover decreased during the follow-up. In the untreated group, BMD decreased at TB and FN, and levels of bone alkaline phosphatase, NTx/creatinine, and galactosyl hydroxylysine/creatinine increased. When the rate of change in BMD (percentage per yr) was compared with that in the control group, bone gain was significant at all three skeletal sites after surgery and HRT, and bone loss was significant at TB and FN, but not at LS, in the untreated group. There was a weak, but significant, correlation between baseline urinary NTx and the change in femoral neck BMD in the untreated group (r = -0.36; P = 0.05). We conclude that untreated postmenopausal women with PHPT have low BMD resulting from accelerated bone loss at the TB and FN. Surgery and HRT both restore BMD and bone turnover toward normal in postmenopausal women with PHPT. A single measurement of bone turnover is insufficient to predict BMD changes in individual patients with PHPT.

Aged↗
PubMed2004

Longitudinal changes of maximal short-term peak power in girls and boys during growth.

PURPOSE: The aims of this study are twofold: first, to analyze the influence of age, body mass, and lean leg volume (LLV) on short-term leg peak power (Pmax) of young females and males during growth using multilevel regression analysis and, second, to compare the regression results of boys and girls. METHODS: The individuals were 100 girls and 109 boys aged 7.5-17.5 yr old. Pmax, LLV, and mass were determined on two occasions using the cycling force-velocity test. The optimal force (Fopt) and pedaling frequency (Vopt) corresponded to the force and pedaling frequency at Pmax. RESULTS: It was observed that the increase of Pmax doesn't depend on gender until the age of 14. From that age, Pmax values are significantly lower in girls than in boys. In girls, LLV is the main predictor of Pmax variance (68%; P < 0.001), whereas in boys it is age (57%; P < 0.001). Results of ANCOVA were that for the same leg length (LL), Vopt is significantly (P < 0.001) higher in boys than in girls. It also indicated that for the same LLV, there are no significant (P > 0.05) gender differences of Fopt. CONCLUSION: These results illustrated that during the growth period, the increase of Pmax is significantly higher in boys than in girls. Qualitative muscular factors (Type II fiber, glycolytic ability, motor coordination, and motor unit activation) may account for the significantly higher Pmax production in boys than in girls. Precisely, the gender differences might be explained by neuromuscular determinants of contraction velocity. In conclusion, children should develop their neuromuscular determinants of contraction velocity rather than their lean leg volume.

Adolescent↗
PubMed2006

Longitudinal changes of brain-type natriuretic peptide in preterm neonates.

OBJECTIVE: To determine age-related concentrations of brain-type natriuretic peptide in preterm infants using bedside Triage brain-type natriuretic peptide test and correlate it to the presence or absence of the patent ductus arteriosus and ventilatory support. METHODS: Serum brain-type natriuretic peptide levels were measured in infants who were born at <32 weeks' gestation from birth to 2 months of age. Serial echocardiograms were performed, until closure of the patent ductus arteriosus, or until discharge. Brain-type natriuretic peptide levels were correlated to the day of life, gestational age, presence or absence of the patent ductus arteriosus, and the degree of ventilatory support. Nineteen preterm infants (gestational age: 24-31 weeks; birth weight: 645-1670 g) were enrolled prospectively during the first 2 weeks of life. Serum brain-type natriuretic peptide levels (pg/mL) were determined in 177 blood samples, and 87 paired echocardiograms were performed. RESULTS: Significant negative correlation was found between brain-type natriuretic peptide levels and the day of life and remained significant when the patients were stratified by gestational age (< or =28 weeks and >28 weeks). Higher brain-type natriuretic peptide levels correlated with increasing grade of the patent ductus arteriosus. Significant differences in brain-type natriuretic peptide levels were seen with increasing ventilatory support. Comparisons between the size of patent ductus arteriosus and the degree of ventilatory support to brain-type natriuretic peptide levels revealed that the size of the patent ductus arteriosus was the major determinant of both brain-type natriuretic peptide levels and the degree of ventilatory support. CONCLUSIONS: Similar to term infants, brain-type natriuretic peptide levels of preterm infants are related to the chronological age and decline during the first month of life. Rapid bedside Triage brain-type natriuretic peptide is a potentially valuable and practical assay in determining the hemodynamic changes in preterm infants.

Ductus Arteriosus, Patent↗
PubMed1999

Relationships between longitudinal changes in radiographic alveolar bone height and probing depth measurements: data from postmenopausal women.

BACKGROUND: The relationship between loss of radiographic alveolar bone height and probing attachment loss has been studied by a number of investigators, with mixed results. Recent studies have found weak correlations and have suggested that the relationship between bone loss and attachment loss is complex, perhaps because changes in bone height and attachment level are separated in time. METHODS: The 85 patients in this report were part of a prospective estrogen replacement interventional study. All patients were in good oral health at entry and received annual oral prophylaxis as part of the study. Standard probing measurements were made with a pressure-sensitive probe at 6 sites on each tooth. Vertical bite-wing radiographs were taken of each patient, radiographs were digitized, and 6 linear measurements (corresponding to probing site measurements) were made from the cemento-enamel junction to the alveolar crest. These procedures were performed at baseline and at annual intervals; this study reports results after 2 years. Data were analyzed both by individual site and by averaging identical sites from all measured teeth for each patient. RESULTS: Very weak direct relationships between change in alveolar bone height and change in attachment level were found in both the site data (r2=0.0022; P = 0.189) and the patient average data (r2=0.031; P= 0.104). CONCLUSIONS: The changes in these patients were probably due to systemic changes in bone health rather than to periodontal disease. However, the weak correlations between changes in attachment level and bone height are similar to recent studies of periodontal disease. Our results support suggestions in the literature that the link between changes in attachment and alveolar bone height is complex, perhaps because changes in the 2 tissue types are separated by a considerable time delay.

Age Factors↗
PubMed1999

Short-term longitudinal changes in subcutaneous fat distribution and body size among Japanese women in the third decade of life.

This research clarified the changes in body shape among Japanese women aged in their 20's, by measuring the subcutaneous fat distribution over the whole body and its circumference at certain points. The subjects, 13 healthy women, were measured twice, once in their early 20's and 5 years later in their late 20's. Subcutaneous fat thickness was measured at 14 points on the body using the B-mode ultrasound method and the body size was measured directly at 8 points on the body using a steel measure. Subcutaneous fat thickness tends to increase with age, except at the cheek, neck, bust and leg. Significant increases were detected especially at lower parts of the trunk such as the waist and infragluteal region. Meanwhile, despite the significant change in subcutaneous fat thickness, the circumferences measured did not change, and also weight tended to decrease with age. Based on this finding, except for fat, body mass, such as muscle and bone, decreases with age due to decreased exercise and changes in calorie intake. Cluster analysis of the accumulation patterns of subcutaneous fat indicated that there were the following 3 patterns of subcutaneous fat accumulation from the early 20's to the late 20's. I. Accumulation on the whole trunk (bust, abdomen, waist and back) and upper arm--trunk/upper arm accumulation pattern. II. Significant accumulation around waist--waist accumulation pattern. III. Even accumulation at abdomen, side abdomen, hip and lower hip--abdomen/hip accumulation pattern.

Adipose Tissue↗
PubMed1989

[Morphological studies on the margo infraorbitalis (on the longitudinal changes of infraorbital suture)].

The purpose of this study was to obtain information on the developmental changes of the infraorbital margin and the form of infraorbital suture. 136 Indian craniums were divided into five developmental groups according to the stage of eruption of the teeth. The anterior view of the skull was observed photographically. The results are summarized as follows: 1. The infraorbital margins were divided into three types according to the shape of the infraorbital suture. Type I: Infraorbital suture was independent. Type II: Infraorbital suture and zygomatico-facial suture coincided. Type III: Infraorbital suture and zygomatico-facial suture were joined. Type I was the basic type of infraorbital suture. 2. The frequency of type I was 90% at the pre-eruption stage, 31.8% at the eruption stage, 41.7% at the deciduous dentition stage, 56.3% at the mixed dentition stage, and 62% at the permanent dentition stage. 3. On the distance between the median line and each point of the infraorbital margin the growth rate is expressed in values relative to a standard that was based on the pre-eruption stage. The growth rate was greatest at the highest point of the superior margin in the infraorbital foramen (1.79 times), the middle rate was at the position of the infraorbital suture (1.72 times) and the smallest rate was 1.63 times at the position of the zygomatico-facial suture. Each measuring point moved towards lateral side.

Cephalometry↗
PubMed1993

Longitudinal changes during the development of hypertension in rats fed excess chloride and sodium.

The effects of supplemental NaCl, KCl, and Na acetate on the blood pressure of weanling rats fed semipurified diets and diets based on naturally high salt products, like cottage cheese, were examined in two studies. Within 2 weeks of initiation of dietary treatments, rats fed supplemental chloride had elevated blood pressure and lowered plasma renin activity, which persisted throughout the 8-week study. The effect of supplemental sodium on blood pressure was not significant until after 6 weeks of dietary treatment. The initial increase in blood pressure preceded the slowed growth observed in rats fed excess chloride or sodium. Urinary volume and urinary excretion of calcium, magnesium, phosphorus, sodium, and chloride were increased when supplemental chloride or sodium was fed, but tissue electrolyte and plasma atrial natriuretic peptide concentrations remained constant. Two changes preceded the rise in blood pressure: rats fed supplemental chloride had enlarged kidneys, and those fed supplemental sodium had elevated hematocrits, suggesting a transient shift among fluid compartments, after only 6 days of treatment. These data suggest that the hypertension induced by ingestion of supplemental (14.6 mg CI/g of diet) chloride is mediated by changes in renal function. Ingestion of excess sodium depressed bone magnesium concentrations in Study 1 and after 24 days in Study 2; the impact of this "relative" magnesium depletion on blood pressure deserves further study.

Acetates↗
PubMed1999

Longitudinal changes in predictor profiles of abstinence from alcohol use among male veterans.

We examined variations in predictors of abstinence depending on the timing of follow-up after alcohol treatment using data from 298 males who completed inpatient treatment at a Midwestern VA Alcoholism Treatment Unit. Our findings indicate fluidity of abstinence and relapse across subjects in the 12 months posttreatment. We also found substantial shifts in the salience of predictors even across short periods of continued abstinence. Methodologically, these findings demonstrate the importance of multiple and closely spaced follow-up points in outcomes research. Substantively, our data support previous findings concerning the impact of increased medical severity, positive employment history, and depression on treatment outcomes.

Adult↗
PubMed2000

Longitudinal changes in cognition, gait, and balance in abstinent and relapsed alcoholic men: relationships to changes in brain structure.

Chronic alcoholism is associated with cognitive and motor deficits, and there is evidence for reversibility with sobriety. Alcoholic men were examined after 1 month of sobriety and 2 to 12 months later with cognitive and motor tests and magnetic resonance imaging. In this naturalistic study, 20 alcoholic participants had abstained and 22 had resumed drinking at retesting. Abstainers sustained greater improvement than relapsers on tests of delayed recall of drawings, visuospatial function, attention, gait, and balance. Shrinkage in 3rd ventricle volume across all participants significantly correlated with improvement in nonverbal short-term memory. Additional brain structure-function relationships, most involving short-term memory, were observed when analyses were restricted to alcoholic men who had maintained complete abstinence, were light relapsers for at least 3 months, or had consumed no more than 10 drinks prior to follow-up testing. Thus, alcoholic men who maintain abstinence can show substantial functional improvement that is related to improvement in brain structure condition.

Adult↗
PubMed2002

Women's sleep: longitudinal changes and secular trends in a 24-year perspective. Results of the population study of women in Gothenburg, Sweden.

STUDY OBJECTIVES: To present observational data on the frequency of sleep problems, sleep duration, and sleep medication in an urban female population. DESIGN: A prospective population study, initiated in 1968-69, with follow-ups in 1974-75, 1980-81, and 1992-93. SETTING: Göteborg, Sweden, with around 445,000 inhabitants. PARTICIPANTS: 1462 women born in 1908, 1914, 1918, 1922, 1930, and 205 women born in 1942 and 1954, a representative selection of women of the respective age in the general population. INTERVENTIONS: NA. MEASUREMENTS: Reported number of hours slept per night, sleep problems, use of sleeping pills, and sleep satisfaction. RESULTS: The frequency of sleep problems increased with age, as did consultations for sleep problems and the use of sleep medication, while no major differences in these parameters could be discerned in a 24-year secular trend analysis of 38- and 50-year-old women, except a lower sleeping pill use in 50-year-old women in 1992-93. An interesting finding was also that the significant reduction of the proportion of 38-year-old women sleeping more than 8 hours per night between 1968-69 and 1980-81 was not accompanied by a secular deterioration in sleep satisfaction in that age group. CONCLUSIONS: Sleep duration decreased by approximately 0.4 hours per night between the ages of 38 and 66. The frequency of sleep problems increased by around 30% between the ages of 38 and 84. The use of sleeping pills also increased, except in the 50-year-old cohort.

Adult↗
PubMed2003

Longitudinal change in left ventricular hypertrophy in the elderly on antihypertensive therapy.

Left ventricular hypertrophy is an independent risk factor for adverse cardiovascular events. Factors related to left ventricular hypertrophy progression or regression in the extremely elderly population including role of antihypertensive therapy, are not well recognized. We conducted a structured retrospective chart review analysis of a cohort of 100 homebound elderly, predominately female African American subjects. All persons had at least two 2-D echocardiograms interpreted by the same cardiologist prior to the initiation of this study. Information was collected on demographics, functional status, comorbid conditions, use of medication, and progression or regression of left ventricle hypertrophy between baseline and follow-up echocardiogram. At baseline and follow-up echocardiogram, 47% (n = 47) and 56% had evidence of hypertrophy, respectively. There was no association between treatment with beta-blocker, calcium channel-blocker, or diuretic therapy, and left ventricular hypertrophy at follow-up echocardiogram. Only angiotensin converting enzyme inhibitor therapy was associated with the progression of left ventricular hypertrophy in all subjects. Logistic regression analysis based on all subjects revealed that risk of left ventricular hypertrophy on follow-up echocardiogram was lower with increasing age (OR 0.95, CI 0.904-0.997) and higher with angiotensin converting enzyme inhibitor therapy (OR 3.27, CI 1.41-7.63). Among subjects with no evidence of left ventricular hypertrophy at baseline, only the presence of hypertension was associated with left ventricular hypertrophy (OR 4.4, CI 1.19-16.3). Treatment of hypertension in the elderly with angiotensin converting enzyme inhibitor seemed to worsen left ventricle hypertrophy in this patient population.

Adrenergic beta-Antagonists↗
PubMed1990

Longitudinal change and interstate variability in the size of residential facilities for persons with mental retardation.

Changes in the size and type of operation of residential facilities for persons with mental retardation in the United States over the past 2 decades were discussed and current (June 30, 1988) interstate variability in residential services along these same dimensions examined. Considerable progress was noted nationally in securing relatively small, community-based residential opportunities for persons with mental retardation. However, this progress has not been uniformly realized in all states or for all types of facilities. Standards for federal policy that would make the official national commitment to community-based services more consistent among all the states were considered.

Health Facility Size↗